Collegium Pharmaceutical, Inc.
USD35.68
-0.30 (-0.82%)
CEO
Vikram Karnani
IPO Date
2015-05-07
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$36.09
Prev. Close
$35.98
Day Low
$35.17
Day High
$36.14
52W Low
$29.19
52W High
$50.79
Market Cap
$1.16B
Volume
0.03M
| 13.4 |
| 31 Dec 2023 | FY | 57.5% | 8.5% | 24.6% | 4.2% | 3.45 | 1.17 | 21.6 |
| 31 Dec 2022 | FY | 45.2% | -5.4% | -12.8% | -2.1% | 3.64 | 0.97 | -31.4 |
| 31 Dec 2021 | FY | 54.4% | 25.8% | 35.2% | 10.3% | 1.28 | 1.13 | 9.1 |
| 31 Dec 2020 | FY | 58.0% | 8.6% | 14.4% | 4.2% | 1.43 | 1.16 | 25.8 |
| 31 Dec 2019 | FY | 34.7% | -7.7% | -26.0% | -7.4% | 0.25 | 1.27 | -30.3 |
| 31 Dec 2018 | FY | 40.9% | -14.0% | -42.7% | -13.4% | 0.13 | 1.27 | -14.4 |
| 31 Dec 2017 | FY | 90.9% | -262.9% | -71.9% | -55.2% | 0.01 | 4.24 | -7.5 |
| 31 Dec 2016 | FY | 87.6% | -5504.1% | -69.8% | -58.1% | 0.03 | 6.92 | -4.0 |
| 21.6 |
| 30 Sept 2025 | Q3 | 61.7% | 15.0% | 11.5% | 2.0% | 3.41 | 1.36 | 8.8 |
| 30 Jun 2025 | Q2 | 57.7% | 6.4% | 5.2% | 0.8% | 3.57 | 1.18 | 19.6 |
| 31 Mar 2025 | Q1 | 54.8% | 1.4% | 1.0% | 0.1% | 3.60 | 1.08 | 98.2 |
| 31 Dec 2024 | Q4 | 54.0% | 6.9% | 5.5% | 0.8% | 3.75 | 0.95 | 18.3 |
| 30 Sept 2024 | Q3 | 60.8% | 5.9% | 4.0% | 0.6% | 3.73 | 0.97 | 33.4 |
| 30 Jun 2024 | Q2 | 62.5% | 13.5% | 9.1% | 1.9% | 2.58 | 1.11 | 13.5 |
| 31 Mar 2024 | Q1 | 63.1% | 19.1% | 12.5% | 2.5% | 2.84 | 1.21 | 11.3 |
| 31 Dec 2023 | Q4 | 63.2% | 21.3% | 16.3% | 2.8% | 3.45 | 1.17 | 7.8 |